Lambert Nicole
- SEC CIK
- 0001770252
No open-market purchases or sales filed in the past year.
Current role at each company
- RCUS Arcus Biosciences, Inc.Directoras of Jun 12, 2026
- MYGN Myriad Genetics IncChief Operating Officeras of Nov 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lambert Nicole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MYGN Myriad Genetics Inc
Chief Operating Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 (view filing) | Mar 27 | 1 day | Lambert NicoleChief Operating Officer | SSale | −6.43K | $23.48 | −$151.0K | −2.6%240.5K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Lambert NicoleChief Operating Officer | SSale | −13.2K | $22.74 | −$299.8K | −5.8%215.2K after | |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Lambert NicoleSee Remarks | SSale | −1.42K | $31.57 | −$44.8K | −0.8%176.7K after | |
| Sep 27, 2021 (view filing) | Sep 27 | Same day | Lambert NicoleSee Remarks | SSale | −10.1K | $33.10 | −$334.7K | −5.4%178.1K after | |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Lambert NicoleSee Remarks | SSale | −945 | $34.50 | −$32.6K | −0.7%127.1K after |